Your browser doesn't support javascript.
loading
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
Follmann, Dean; O'Brien, Meagan P; Fintzi, Jonathan; Fay, Michael P; Montefiori, David; Mateja, Allyson; Herman, Gary A; Hooper, Andrea T; Turner, Kenneth C; Chan, Kuo- Chen; Forleo-Neto, Eduardo; Isa, Flonza; Baden, Lindsey R; El Sahly, Hana M; Janes, Holly; Doria-Rose, Nicole; Miller, Jacqueline; Zhou, Honghong; Dang, Weiping; Benkeser, David; Fong, Youyi; Gilbert, Peter B; Marovich, Mary; Cohen, Myron S.
Afiliación
  • Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. dfollmann@niaid.nih.gov.
  • O'Brien MP; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Fintzi J; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Fay MP; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Montefiori D; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • Mateja A; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Herman GA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Hooper AT; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Turner KC; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Chan KC; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Forleo-Neto E; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Isa F; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Baden LR; Brigham and Women's Hospital, Boston, MA, USA.
  • El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
  • Janes H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Doria-Rose N; Vaccine Research Center, National Institutes of Health, Bethesda, MD, USA.
  • Miller J; Moderna, Inc., Cambridge, MA, USA.
  • Zhou H; Moderna, Inc., Cambridge, MA, USA.
  • Dang W; Moderna, Inc., Cambridge, MA, USA.
  • Benkeser D; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Gilbert PB; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Marovich M; Department of Biostatistics, University of Washington, Seattle, WA, USA.
  • Cohen MS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Nat Commun ; 14(1): 3605, 2023 06 17.
Article en En | MEDLINE | ID: mdl-37330602
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Anticuerpos Monoclonales Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Anticuerpos Monoclonales Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido